STOCK TITAN

IREN Ltd (IREN) SEC Filings, Jul-Sep 2025

IREN NASDAQ
Rhea-AI Summary

Daniel John Roberts, identified as a Director and Co-Chief Executive Officer of IREN Limited (IREN), filed a Form 4 reporting option transactions dated 09/03/2025 and 09/04/2025. The filing reports two sets of stock options to purchase ordinary shares that expire on December 20, 2025, each for 500,000 options. The exercise price of each option is AUD $5.005 per share (converted at the filing exchange rate to USD $3.27 per option). The filing states the options are fully vested and exercisable and are held through the Awassi Capital Trust #2, with the reporting person disclaiming beneficial ownership except for his pecuniary interest. The filing includes a signature dated 09/05/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

William Gregory Roberts, a director and Co-Chief Executive Officer of IREN Limited, filed a Form 4 reporting two derivative security transactions dated 09/03/2025 and 09/04/2025. The filings relate to options to purchase ordinary shares that expire on December 20, 2025. Each reported line shows 500,000 options with an exercise price of AUD $5.005 per share, converted using the transaction date exchange rate of USD $1.00 = AUD $1.53 (reported as USD $3.27 per option). The Form states the options are fully vested and exercisable and are held through Awassi Capital Trust #1, with the reporting person disclaiming beneficial ownership except for his pecuniary interest. The filing was signed by an attorney-in-fact on 09/05/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Summary

IREN Limited filed a post-effective amendment to its shelf registration and a prospectus supplement dated August 28, 2025, updating offerings under its Form S-3. The filing registers loan-funded shares and ordinary share resales, including up to 1,214,935 ordinary shares related to loan agreements and up to 2,000,000 ordinary shares potentially issuable to B. Riley Capital, LLC from exercisable options. A sales agreement prospectus supplement contemplates at-market sales under an amended issuance agreement with multiple dealers, including capacity to issue and sell up to $1,000,000,000 of ordinary shares under the sales agreement prospectus supplement.

The prospectus states use of any net proceeds for growth initiatives such as hardware purchases, data center development and working capital. It discloses key metrics: 271,980,494 ordinary shares outstanding as of August 15, 2025; 7,878,554 options outstanding at a weighted-average exercise price of $47.77; and 30,066,642 restricted share units outstanding. It reiterates material risks including Bitcoin price and global hashrate volatility, electricity and supply constraints, evolving tax and regulatory treatment of digital assets, potential litigation and financing risks, and that the last reported Nasdaq sale price was $22.36 on August 27, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.93%
Tags
registration
Rhea-AI Summary

IREN Limited filed a current report to note that it has released its financial results for the fourth quarter and full fiscal year ended June 30, 2025.

The company announced these results in a press release dated August 28, 2025, which is furnished as Exhibit 99.1. This press release is provided for information but is not treated as formally filed for liability purposes or automatically incorporated into other securities filings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.93%
Tags
current report
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
current report
Rhea-AI Summary

Schedule 13G/A (Amendment 2) filed 3 July 2025 discloses that The Awassi Capital Trust #2, Awassi Capital Holdings 2 Pty Ltd and Daniel John Roberts jointly own 6,251,247 ordinary shares of IREN Limited. This represents 2.41 % of IREN’s outstanding equity as of the event date 30 June 2025.

All voting and dispositive authority is shared; none of the three reporting persons holds sole power over the securities. The filing is made on Schedule 13G rather than 13D, signalling a passive investment posture with no intent to influence control. Because the stake is below the 5 % threshold, the group is no longer considered a “significant beneficial owner” under SEC rules, limiting its ability to affect governance matters or strategic direction.

  • Reporting persons: The Awassi Capital Trust #2; Awassi Capital Holdings 2 Pty Ltd; Daniel John Roberts (all Australian)
  • Shares owned: 6,251,247
  • Percent of class: 2.41 %
  • Sole voting/dispositive power: 0
  • Shared voting/dispositive power: 6,251,247

No additional agreements, transactions, or changes of control are reported, and the certification states the information is true and complete.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.41%
Tags
insider

FAQ

How many IREN (IREN) SEC filings are available on StockTitan?

StockTitan tracks 77 SEC filings for IREN (IREN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for IREN (IREN)?

The most recent SEC filing for IREN (IREN) was filed on September 6, 2025.